Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Pouliquen

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
The British Journal of Ophthalmology|June 23, 2007
Clinical and biological efficacy of preservative-free NAAGA eye-drops versus levocabastine eye-drops in vernal keratoconjunctivitis patientsA Leonardi, D Bremond-Gignac, M Bortolotti, et al.
The British Journal of Ophthalmology|April 20, 2006
Comparison of a non-preserved 0.1% T-Gel eye gel (single dose unit) with a preserved 0.1% T-Gel eye gel (multidose) in ocular hypertension and glaucomatous patientsD L Easty, G Nemeth-Wasmer, J-P Vounatsos, et al.
European Journal of Ophthalmology|January 19, 2008
Tear concentrations of azithromycin following topical administration of a single dose of azithromycin 0.5%, 1.0%, and 1.5% eyedrops (T1225) in healthy volunteersF Chiambaretta, R Garraffo, P P Elena, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 16, 2007
Safety and immunogenicity of subcutaneous or intramuscular administration of a monovalent inactivated vaccine against Leptospira interrogans serogroup Icterohaemorrhagiae in healthy volunteersH Laurichesse, F Gourdon, H L Smits, et al.
The British Journal of Ophthalmology|March 22, 2008
Prevalence of vernal keratoconjunctivitis: a rare disease?D Bremond-Gignac, J Donadieu, A Leonardi, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
The British Journal of Ophthalmology|June 23, 2007
Clinical and biological efficacy of preservative-free NAAGA eye-drops versus levocabastine eye-drops in vernal keratoconjunctivitis patientsA Leonardi, D Bremond-Gignac, M Bortolotti, et al.
The British Journal of Ophthalmology|April 20, 2006
Comparison of a non-preserved 0.1% T-Gel eye gel (single dose unit) with a preserved 0.1% T-Gel eye gel (multidose) in ocular hypertension and glaucomatous patientsD L Easty, G Nemeth-Wasmer, J-P Vounatsos, et al.
European Journal of Ophthalmology|January 19, 2008
Tear concentrations of azithromycin following topical administration of a single dose of azithromycin 0.5%, 1.0%, and 1.5% eyedrops (T1225) in healthy volunteersF Chiambaretta, R Garraffo, P P Elena, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 16, 2007
Safety and immunogenicity of subcutaneous or intramuscular administration of a monovalent inactivated vaccine against Leptospira interrogans serogroup Icterohaemorrhagiae in healthy volunteersH Laurichesse, F Gourdon, H L Smits, et al.
The British Journal of Ophthalmology|March 22, 2008
Prevalence of vernal keratoconjunctivitis: a rare disease?D Bremond-Gignac, J Donadieu, A Leonardi, et al.
Pageof 2